Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Current Opinion in Pharmacology|August 15, 2006
Novel targets for tuberculosis drug discoveryKhisimuzi Mdluli, Melvin SpigelmanInfectious Disorders Drug Targets|November 1, 2007
Mycobacterium tuberculosis DNA gyrase as a target for drug discoveryKhisimuzi Mdluli, Zhenkun MaFuture Medicinal Chemistry|September 2, 2011
Challenges and opportunities in developing novel drugs for TBTakushi Kaneko, Christopher Cooper, Khisimuzi MdluliAnnals of the New York Academy of Sciences|June 13, 2014
Tuberculosis drug discovery and emerging targetsKhisimuzi Mdluli, Takushi Kaneko, Anna UptonCold Spring Harbor Perspectives in Medicine|January 31, 2015
The tuberculosis drug discovery and development pipeline and emerging drug targetsKhisimuzi Mdluli, Takushi Kaneko, Anna UptonAntimicrobial Agents and Chemotherapy|February 2, 2021
Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of TuberculosisJian Xu, Paul J Converse, Anna M Upton, et al.Antimicrobial Agents and Chemotherapy|November 15, 2023
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosisDeepak Almeida, Si-Yang Li, Jin Lee, et al.Antimicrobial Agents and Chemotherapy|June 21, 2017
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisSi-Yang Li, Rokeya Tasneen, Sandeep Tyagi, et al.Antimicrobial Agents and Chemotherapy|May 18, 2016
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosisDeepak Almeida, Thomas Ioerger, Sandeep Tyagi, et al.CPT: Pharmacometrics & Systems Pharmacology|February 26, 2024
A systematic efficacy analysis of tuberculosis treatment with BPaL-containing regimens using a multiscale modeling approachMaral Budak, Laura E Via, Danielle M Weiner, et al.Pageof 4